
News|Articles|October 1, 2012
Children with arthritis face elevated cancer risk
Children diagnosed with juvenile idiopathic arthritis (JIA) have triple the risk for cancer, and the findings hold for those who were never treated with biologic therapies for JIA, according to a new study.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves risankizumab for pediatric plaque psoriasis and psoriatic arthritis
2
FDA fast tracks BM-3103 gel for epidermolysis bullosa simplex
3
FDA updates in pediatric care: Q2 2026 recap
4
5 FDA decisions to watch for during 2H 2026
5





